Estimating the lifetime economic burden of stroke according to the age of onset in South Korea: A cost of illness study

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Kang, Hye Young ^a   Lim, Seung Ji ^a   Suh, Hae Sun ^a   Liew, Danny ^b  

^a Yonsei University   (South Korea)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cost of illness; Republic of Korea; Stroke

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; COST OF ILLNESS; ECONOMICS; FEMALE; HUMAN; LIFE EXPECTANCY; MALE; MIDDLE AGED; ONSET AGE; PROBABILITY; SOUTH KOREA; STROKE;

AGE DISTRIBUTION; AGE OF ONSET; AGED; AGED, 80 AND OVER; COST OF ILLNESS; FEMALE; HUMANS; LIFE EXPECTANCY; MALE; MARKOV CHAINS; MIDDLE AGED; REPUBLIC OF KOREA; STROKE;

EID: 80051587435     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-646     Document Type: Article

References (36)

1. Report on death causes. Korea National Statistical Office, Daejeon: KNSO 2005
2. Report on death causes. Korea National Statistical Office, Daejeon: KNSO 2006
3. Economic burden of cardiovascular diseases in the enlarged European Union. Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M, Eur Heart J 2006 27 13 1610 1619 10.1093/eurheartj/ehi733 16495286 (Pubitemid 43954923)
4. Cost of cardiovascular diseases in the United Kingdom. Luengo-Fernandez R, Leal J, Gray A, Petersen S, Rayner M, Heart 2006 92 10 1384 1389 10.1136/hrt.2005.072173 16702172 (Pubitemid 44578822)
5. The Korea National Health and Nutrition Examination Survey (KNHANES I). Korea Center for Disease Control and Prevention, Seoul: Korea Ministry of Health, Welfare, and Family Affairs 1998
6. The Korea National Health and Nutrition Examination Survey (KNHANES III). Korea Center for Disease Control and Prevention, Seoul: Korea Ministry of Health, Welfare, and Family Affairs 2005
7. Lifetime cost of stroke subtypes in Australia: findings from the North East Melbourne Stroke Incidence Study (NEMESIS). Dewey HM, Thrift AG, Mihalopoulos C, Carter R, Macdonell RA, McNeil JJ, Donnan GA, Stroke 2003 34 10 2502 2507 10.1161/01.STR.0000091395.85357.09 12970517 (Pubitemid 37221972)
8. Direct costs during the first year after intracerebral hemorrhage. Porsdal V, Boysen G, Eur J Neurol 1999 6 4 449 454 10.1046/j.1468-1331.1999. 640449.x 10362898 (Pubitemid 29371142)
9. Costs of coronary heart disease and stroke: the case of Sweden. Zethraeus N, Molin T, Henriksson P, Jonsson B, J Intern Med 1999 246 2 151 159 10.1046/j.1365-2796.1999.00546.x 10447784 (Pubitemid 29378920)
10. Estimating the long-term costs of ischemic and hemorrhagic stroke for Australia: new evidence derived from the North East Melbourne Stroke Incidence Study (NEMESIS). Cadilhac DA, Carter R, Thrift AG, Dewey HM, Stroke 2009 40 3 915 921 10.1161/STROKEAHA.108.526905 19182091
11. The economic burden of stroke in Italy. The EcLIPSE Study: Economic Longitudinal Incidence-based Project for Stroke Evaluation. Gerzeli S, Tarricone R, Zolo P, Colangelo I, Busca MR, Gandolfo C, Neurol Sci 2005 26 2 72 80 10.1007/s10072-005-0439-0 15995823 (Pubitemid 40975507)
12. Overview of costs of stroke from published, incidence-based studies spanning 16 industrialized countries. Palmer AJ, Valentine WJ, Roze S, Lammert M, Spiesser J, Gabriel S, Curr Med Res Opin 2005 21 1 19 26 10.1185/ 030079904X17992 15881472 (Pubitemid 40327502)
13. Briggs A, Claxton K, Sculpher M, Decision modelling for health economic evaluation Oxford: Oxford University Press 2006
14. Construction of national surveillance system for cardiovascular & cerebrovascular diseases. Health Insurance Review and Assessment Services, Seoul: Health Insurance Review and Assessment Services 2006
15. The WHO STEPwise approach to stroke surveillance: Overview and manual (Ver 2.0). World Health Organization, Geneva: World Health Organization 2004
16. The American Heart Association Stroke Outcome Classification: Executive Summary. Kelly-Hayes M, Robertson JT, Broderick JP, Duncan PW, Hershey LA, Roth EJ, Thies WH, Trombly CA, Circulation 1998 97 24 2474 2478 9641702 (Pubitemid 28278194)
17. Outcome Measure and Efficacy Analysis in Stroke Clinical Trials. Hong KS, J Korean Neurol Assoc 2006 24 5 411 420
18. Long-term survival and causes of death after stroke. Bronnum-Hansen H, Davidsen M, Thorvaldsen P, Stroke 2001 32 9 2131 2136 10.1161/hs0901.094253 11546907 (Pubitemid 32868112)
19. Report on wage structure. Korea National Statistical Office, Gwacheon: Ministry of Employment and Labor 2005
20. Report on wage structure. Korea National Statistical Office, Gwacheon: Ministry of Employment and Labor 2006
21. Statistics Korea, Korean Statistical Information Service, Consumer Price Index, 2008 http://kosis.kr accessed on March 15, 2011
22. Gold MR, Siegel JE, Russell LB, Weinstein MC, Cost-effectiveness in health and medicine New York: Oxford University Press 1 1996
23. The economic burden of stroke in the United Kingdom. Youman P, Wilson K, Harraf F, Kalra L, Pharmacoeconomics 2003 21 Suppl 1 43 50 12648034 (Pubitemid 36332383)
24. Cost of stroke in the United Kingdom. Saka O, McGuire A, Wolfe C, Age Ageing 2009 38 1 27 32 19141506
25. Survey results of medical costs for uncovered services for selected diagnosis and procedures in Korea. National Health Insurance Corporation, Seoul: National Health Insurance Corporation 2005
26. Survey results of medical costs for uncovered services for selected diagnosis and procedures in Korea. National Health Insurance Corporation, Seoul: National Health Insurance Corporation 2006
27. Utilization of health care resources and costs of stroke patients: patients' perspective. Lee KS, Bae JH, Kim HS, Journal of the Korean Neurological Association 2004 22 583 589
28. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL, Methods for the economic evaluation of health care programmes Oxford: Oxford University Press 3 2006
29. A practical guide for calculating indirect costs of disease. Koopmanschap MA, Rutten FF, Pharmacoeconomics 1996 10 5 460 466 10.2165/00019053-199610050- 00003 10172868 (Pubitemid 26359874)
30. The friction cost method for measuring indirect costs of disease. Koopmanschap MA, Rutten FFH, van Ineveld BM, van Roijen L, Journal of Health Economics 1995 14 2 171 189 10.1016/0167-6296(94)00044-5 10154656
31. Economic activities census. Statistics Korea & Ministry of Strategy and Finance, https://www.index.go.kr/egams/stts/jsp/potal/stts/PO-STTS-IdxMain. jsp?idx-cd = 1063&bbs=INDX-001 last updated on May 19, 2011; accessed on June 15, 2011
32. International comparisons: The American Society for Training & Development (ASTD)'s annual accounting of worldwide patterns in employer-provided training. Marquardt MJ, King SB, Ershkine W, Alexandria, VA, USA: The American Soceity for Training & Development (ASTD) 2002
33. Estimating socioeconomic costs of five major diseases. Chung YH, Ko SJ, Korean Journal of Public Finance 2004 18 77 104
34. Economic burden of stroke and the evaluation of new therapies. Kaste M, Fogelholm R, Rissanen A, Public Health 1998 112 2 103 112 9581452 (Pubitemid 28161901)
35. Strategies to enhance the use of National Health Insurance claims database in generating health statistics. Kim JY, Technical report by Health Insurance Review and Assessment Services 2005
36. Strategies to improve the validity of diagnostic codes of National Health Insurance claims data. Park BJ, Sung JH, Park KD, Seo SW, Kim SW, Technical report by Health Insurance Review and Assessment Services 2002